75 Units of Tirzepatide: What the Measurement Actually Means

Why does tirzepatide get talked about in "units" at all?

The confusion starts with how tirzepatide reaches different markets. In the UK, Mounjaro comes as a pre-filled KwikPen containing a set concentration: each pen holds four weekly doses, and those doses are described in milligrams. There is nothing for a patient to draw, dilute or measure.

"Units" enters the picture when people use tirzepatide sourced as a research-grade or compounded vial, common in contexts where the pre-filled pen is unavailable or unaffordable. In that scenario, someone draws the liquid into an insulin syringe whose barrel is marked in units (hundredths of a millilitre), then converts to reach the milligram target. On a standard U-100 insulin syringe, 75 units equals 0.75ml. Whether that volume delivers a meaningful tirzepatide dose depends entirely on the vial's concentration, and that figure varies, which is exactly where dosing errors creep in.

The resource on how tirzepatide units relate to licensed doses covers that conversion question in full. The short version: if you are using a licensed Mounjaro KwikPen from a regulated UK pharmacy, you will never need to think about units at all.

For a broader grounding in how tirzepatide works and what it is licensed for, the tirzepatide overview is a good starting point.

What does 75 units actually correspond to in milligrams, and does it match a licensed dose?

The arithmetic is straightforward, but the answer depends on concentration. Research vials of tirzepatide are typically prepared at 5mg/ml, though concentrations of 2mg/ml, 4mg/ml and higher exist. On a 5mg/ml vial, 0.75ml (75 units on a U-100 syringe) would contain 3.75mg of tirzepatide. That sits between the licensed 2.5mg starter dose and the 5mg second-step dose, it does not correspond to any step in the Mounjaro titration schedule at all.

Change the concentration to 4mg/ml and the same 75 units delivers 3mg. At 2mg/ml it delivers 1.5mg. The same syringe marking produces three entirely different biological doses depending on a number printed on a vial the buyer may never have independently verified. This is not a theoretical risk. The MHRA has publicly warned about counterfeit and unregulated weight-loss injectables, noting that fake pens have in some cases contained insulin rather than the stated compound.

The NHS medicine information page for tirzepatide on NHS.uk describes the licensed dose steps clearly. None list a 3.75mg or 3mg step.

If you are curious about what specific licensed amounts look like in practice, the pages on 50 units of tirzepatide and 25 units of tirzepatide address those specific syringe markings using the same framework.

What does the licensed Mounjaro KwikPen actually deliver, and what arrives with it?

When tirzepatide is dispensed through the licensed UK supply chain, the patient receives a KwikPen containing four weekly doses at the prescribed strength. The pen dials, clicks and injects without the user handling a syringe or calculating a volume. Treatment begins at 2.5mg, a dose chosen to help the body adjust gradually, with titration managed by the prescriber over subsequent months. The six available strengths run up to 15mg.

Practically speaking: the pen arrives in a plain, unbranded DPD parcel with tracking sent to your phone, stored in the fridge on arrival. No assembly, no dilution, no conversion. The patient information leaflet inside covers injection technique, storage and what to do if a dose is missed, questions of timing and dose adjustment always go back to your prescriber, not a forum conversion table.

The guide to tirzepatide units and dosing explains why the pen format makes unit calculations irrelevant for licensed patients. For anyone weighing up treatment options more broadly, the weight-loss treatment overview sets out what is available.

Is seeking tirzepatide in vial form to reach 75 units safe or legal in the UK?

Tirzepatide is a prescription-only medicine. Sourcing it without a valid prescription (in any form, vial or pen) is illegal under the Human Medicines Regulations 2012. Beyond the legal question, the practical risks with unlicensed vials are considerable: no guaranteed purity, no regulated concentration, no clinical oversight for dose increases, and no recourse if something goes wrong.

NICE's appraisal of tirzepatide (TA1026) recommends it within a clinical framework that includes prescriber oversight and regular review. That framework exists because the medicine is potent and the titration schedule matters. Starting too high causes unnecessary side effects; staying too low means limited benefit; dose increases without clinical checks are simply guesswork.

The Mounjaro information page covers the full UK clinical picture. If you want to understand the cost side of licensed private treatment, the guide to buying Mounjaro online safely addresses what a legitimate prescription service includes and what separates it from unregulated sellers. Our clinical team reviews every consultation personally, a real prescriber, not an automated system, reads your answers before any treatment is approved.

If you think you may be eligible for tirzepatide and want a proper clinical assessment, starting a free consultation is the right next step.